BTK and prostate cancer: In prostate cancer cell lines, down regulation of this protein with RNA interference or inhibition with BTKi, ibrutinib, spebrutinib and CGI-1746, all decreased cell survival and induced apoptosis via an on-target BTK mediated effect [47].